好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cold Case: Profound Hypothermia as an Atypical Early Manifestation of Paraneoplastic ROHHAD-NET Syndrome in an Adolescent
Autoimmune Neurology
P2 - Poster Session 02 (3:00 PM-4:00 PM)
1-100

To expand the known phenotypic spectrum of paraneoplastic ROHHAD-NET (rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation - associated with neuroendocrine tumors).

ROHHAD-NET is a rare and incompletely characterized paraneoplastic disease, typically presenting in young pre-pubertal children with rapid weight gain followed by sleep disordered breathing, and eventually life threatening hypothalamic/autonomic failure. We present a highly atypical case of ROHHAD-NET in a teenager which did not follow this expected trajectory.

We performed a retrospective descriptive chart review of a single case.

A 13 year old girl with idiopathic growth hormone deficiency presented with unexplained hypothermia. She developed sudden confusion and tremulousness at school without provoking cause, and was found to be extremely cold to touch. Initial vitals confirmed profound hypothermia (temp 32 C) and associated bradycardia (HR 30-50) requiring passive external warming in the intensive care unit. Extensive workup included negative toxicology screening, normal endocrine/hormonal labs, normal brain and spine MRI, negative serum/CSF autoimmune antibodies (including autonomic ganglionopathy panel), and non-diagnostic comprehensive exome sequencing. Hypothermia improved with initiation of alpha agonist and she was discharged. Over the next several months she weaned off the alpha agonist, but developed progressive weight gain with BMI increase from 28.86 kg/m2 to 38.63 kg/m2 (12 month span). Full body MRI revealed a thoracic paraspinal mass, which was resected and confirmed to be ganglioneuroma. Polysomnography showed severe obstructive sleep apnea, without central apnea/hypoventilation. Re-analysis of genetic testing for PHOX2B pathogenic variants/repeats was negative. She was clinically diagnosed with ROHHAD-NET, and initiated immune therapy with intravenous immunoglobulin (1 g/kg monthly). Following tumor resection and IVIG initiation her BMI improved (34.88 kg/m2 after 6 months of treatment) and she has had no further autonomic instability. 

ROHHAD-NET is not exclusive to young children, and autonomic/hypothalamic failure may precede the onset of rapid weight gain.

Authors/Disclosures
Varun Kannan, MD (Emory/CHOA)
PRESENTER
Dr. Kannan has nothing to disclose.
Ajay S. Kasi, MD Dr. Kasi has nothing to disclose.
Prabhumallikarjun Patil, MD (Childrens health care of atlanta) Dr. Patil has nothing to disclose.
Madeleine H. McLaughlin, MD (Emory) Dr. Hebert has nothing to disclose.
Grace Gombolay, MD, FAAN (Emory University/Children'S Healthcare of Atlanta) Dr. Gombolay has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH. Dr. Gombolay has a non-compensated relationship as a Board of Trustee with National MS Society -Georgia chapter that is relevant to AAN interests or activities.